Skip to main content
OpenTrials

Clinical trial condition

Ovarian Neoplasms

Explore clinical trials studying Ovarian Neoplasms. Study availability and eligibility vary by location and protocol.

296 public trials 52 recruiting studies
Refine in advanced search Browse all conditions

Ovarian Neoplasms trial results

Completed

Acute Normovolemic Hemodilution in Patients Undergoing Cytoreductive Surgery for Advanced Ovarian Cancer

NCT01442051

Conditions
Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +21 more
Locations
  • Memoral Sloan Kettering Cancer Center Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Cancer Center @ Suffolk Commack, New York, United States
  • Memorial Sloan Kettering West Harrison Harrison, New York, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
View Trial Details
Completed

E-MOSAIC Electronic Tool to Monitor Symptoms

NCT00477919

Conditions
Adenocarcinoma, Adenoma, Adnexal Diseases, +115 more
Locations
  • Universitaetsspital-Basel Basel, Switzerland
  • Istituto Oncologico della Svizzera Italiana - Ospedale San Giovanni Bellinzona, Switzerland
  • Inselspital Bern Bern, Switzerland
  • Spital Buelach Bülach, Switzerland
View Trial Details
Completed

Prasterone (Dehydroepiandrosterone) in Treating Postmenopausal Cancer Survivors With Vaginal Symptoms

NCT01376349

Conditions
Adnexal Diseases, Anxiety Disorders, Behavior, +39 more
Locations
  • Mayo Clinic Scottsdale Scottsdale, Arizona, United States
  • Aurora Presbyterian Hospital Aurora, Colorado, United States
  • Boulder Community Hospital Boulder, Colorado, United States
  • Penrose Cancer Center at Penrose Hospital Colorado Springs, Colorado, United States
View all 280 locations
View Trial Details
Completed

Study of Talazoparib, a PARP Inhibitor, in Patients With Advanced or Recurrent Solid Tumors

NCT01286987

Conditions
Adnexal Diseases, Advanced or Recurrent Solid Tumors, Breast Diseases, +49 more
Locations
  • Scottsdale Healthcare Scottsdale, Arizona, United States
  • Virginia G. Piper Cancer Center Research Pharmacy Scottsdale, Arizona, United States
  • (IRB# 12-000131) Ronald Reagan UCLA Medical Center, Drug Information Center Los Angeles, California, United States
  • Ronald Reagan UCLA Medical Center Los Angeles, California, United States
View all 15 locations
View Trial Details
Completed

Cediranib Maleate in Treating Patients With Persistent, Recurrent, or Refractory Advanced Ovarian Epithelial, Peritoneal Cavity, or Fallopian Tube Cancer

NCT00278343

Conditions
Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +21 more
Locations
  • City of Hope Duarte, California, United States
  • University of Southern California/Norris Cancer Center Los Angeles, California, United States
  • City of Hope Medical Group Inc Pasadena, California, United States
  • University of California at Davis Cancer Center Sacramento, California, United States
View all 28 locations
View Trial Details

Related conditions